| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8227078 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 7 Pages |
Abstract
The prognosis of ESS differed from that of UES. Endometrial stromal sarcomas had an excellent 5-year OS, whereas the OS in UES was rather low. However, half of ESS patients had a relapse. For this reason, adjuvant treatment such as RT should be considered even in low-grade tumors. Multicenter randomized studies are still warranted to establish clear guidelines.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ulrike M.D., Yasmin M.D., Juliette M.D., Roxolyana M.D., Abraham M.D., Sefik M.D., Hale M.D., Zeynep M.D., Kristina M.D., Ursula M.D., Daniel M.D., Sylviane M.D., Hansjörg M.D.,